McKesson Canada names new president of payer markets
MISSISSAUGA, Ontario — McKesson Canada on Tuesday announced the appointment of Dianne Carmichael as president payer markets and head of corporate strategy and business development, effective immediately. Reporting to Domenic Pilla, McKesson Canada’s CEO, Carmichael will be responsible for developing and executing on McKesson Canada’s payor market strategy, and identifying how to create and deliver value to patients, providers and insurers.
In this role, Carmichael will also oversee McKesson’s overall corporate strategy and M&A activities in Canada.
“Dianne is an innovative and inspired leader with over 25 years of executive management experience and a proven track record of building and growing businesses,” Pilla said. "I am confident she will provide a valuable perspective on the challenges and opportunities facing health care in Canada and help position the organization for long-term success.”
Carmichael has held various senior roles within the consumer packaged goods, technology, financial services and health care industries. As chairman and CEO Worldsource Wealth Management at publicly traded Guardian Capital, she created and built an $8 billion pension, wealth and mutual management company. She went on to help build and lead a number of innovative organizations with an international footprint, including Best Doctors, an employee benefits company that covers 40 million people worldwide, including 6 million Canadians, UHN Solutions at University Health Network and Health Innovation & Ventures at MaRS.
Most recently she was the chief health tech advisor at the Council of Canadian Innovators.
Carmichael is a founding board member of Patients Canada and sits on the board of the Centre for the Commercialization of Regenerative Medicines. She has received many awards including Top 20 Business Women in Canada, Top 100 Business Leaders in Canada, Canadian Women Transforming Health Care and WXN's Top 100 Most Powerful Women in Canada.
Walgreens adds almost 1,000 medication disposal kiosks into stores
DEERFIELD, Ill. — Healthcare organizations AmerisourceBergen, Blue Cross Blue Shield Association, Pfizer and Prime Therapeutics on Tuesday joined Walgreens to combat the national opioid abuse crisis by expanding the availability of safe medication disposal kiosks to an additional 900 Walgreens stores near military bases and other areas where the opioid epidemic has challenged communities.
When the expansion is complete, kiosks will be available in approximately 1,500 Walgreens stores nationwide.
“We are proud to work with organizations from throughout the health care community to make it even easier for people to dispose of their unwanted medications,” stated Alex Gourlay, president of Walgreens. “Since launching this program in 2016, we have been truly inspired by the response of the safe medication disposal program from communities around the country. The expansion of this program is a great example of health care organizations coming together in collaboration to address a real health crisis facing the country.”
"As a supply chain partner, we are committed to finding comprehensive solutions to mitigate the opioid epidemic impacting our communities, and we understand the important role we play in helping to combat medication diversion and abuse,” added Bob Mauch, EVP and group president, Pharmaceutical Distribution & Strategic Global Sourcing for AmerisourceBergen. "Innovation and collaboration between all parties involved in the delivery and regulation of health care will drive the greatest progress in impacting the opioid crisis, and the diverse partnership supporting the expansion of Walgreens highly successful safe medication disposal program is a strong example of the type of collaboration that's needed.”
In the midst of the opioid epidemic, military members have emerged as a particularly vulnerable population. By expanding the focus to serve military communities, the organizations aim to help curb the misuse of medications that, according to the National Institute of Drug Abuse, is higher among service members than civilians. Through the safe medication disposal kiosks, military communities will now have access to a safe way to dispose of their unwanted or unused prescription medications.
The announcement builds upon the initial 600 safe medication disposal kiosks Walgreens installed beginning in 2016 across 45 states and the District of Columbia. Those kiosks have collected 155 tons of unwanted medications in the first 18 months of the program. With this expansion, the organizations have set a goal to collect an additional 300 tons of unwanted medication in the next two years.
A recent survey conducted by Prime revealed people taking opioids may not know how to safely dispose of unused medications. Only 17% had spoken with their doctor about safe disposal of unused medicine. Additionally, nearly a quarter of adults keep unused opioids instead of disposing of them, and only 27% of those who dispose of old medicine use a take back program to safely dispose of controlled substances. This data reveals there is a need to encourage safe disposal and that more take back locations is one way to promote safety.
“This crisis calls for an all-hands-on-deck approach,” said Jonathan Gavras, SVP and chief medical officer, Prime Therapeutics. “Prime is proud to be sponsoring this take back kiosk initiative – as an extension of Prime’s existing Controlled Substances Management Program – because we not only need to monitor for appropriate use, we need to make sure these dangerous medicines don’t fall into the wrong hands. We encourage everyone to go through their medicine cabinets and drop their unwanted medicines safely into a nearby Walgreens kiosk.”
Helping to achieve the goal to collect 300 additional tons of unwanted medication in two years is the #ItEndsWithUs campaign, recently launched by Walgreens to educate teens on the opioid epidemic. The campaign provides teens with online resources to end the opioid epidemic and positive steps they can take within their communities, including how to dispose of unwanted medications. The 900 additional kiosks will be installed over the next 10 months.
Safe medication disposal kiosks allow individuals to safely and conveniently dispose of their unwanted, unused or expired prescriptions, including controlled substances, and over-the-counter medications, at no cost. The kiosks at Walgreens pharmacies are available during regular pharmacy hours and offer one of the best ways to ensure medications are not accidentally used or intentionally misused by someone else.
CVS Pharmacy debuts ScriptPath Prescription Schedule
WOONSOCKET, R.I. — CVS Pharmacy’s latest initiative is making medication management easier for patients with multiple prescriptions. The company has debuted the ScriptPath Prescription Schedule, which shows all of a patient’s current prescription information in one place. The schedule features easy-to-understand icons that indicated when a patient should take a medication and how much should be taken in each dose.
The ScriptPath Prescription Schedule looks to meet the needs of the 50% of patients who report confusion about how and when to take their medications, as well as patients with complex prescription regimens. With the initiative, patients with five or more medications will automatically receive counseling from the pharmacist about their medication and be given a ScriptPath Prescription Schedule, and any patient or their caregiver can request one. In addition to meeting patient needs, the initiative is bringing patients more touch points with pharmacists, CVS Pharmacy EVP pharmacy services Kevin Hourican told Drug Store News.
“We are a pharmacy innovation company, our purpose is to help people on their path to better health. We know there's tremendous confusion out there … [and] our pharmacists want to do this kind of work,” Hourican said. “We want to be able to holistically understand the patient's medication regimen and more importantly, help the patient understand their medication regimen and counsel them on the medication they're taking and the front-store products they're taking to go along with it.”
Hourican said that in its beta stage, pharmacists helped counsel 50,000 patients who were taking their medications at the wrong time within the larger population of patients counseled. And with it now live in CVS Pharmacy's more than 9,700 retail pharmacy locations, the patient population that will automatically receive counseling is roughly 9 million patients.
The information for the ScriptPath Prescription Schedule is generated through a robust clinical engine that uses prescriber instructions to provide dosage and interval information and reconcile dosing times across a patient’s medication regimen. It also can understand prescriptions in English s and Spanish. CVS Pharmacy also has planned a 2018 roll out of a new prescription label, designed by the mind behind Target’s ClearRx prescription packaging system and inventor and lead designer of the ScriptPath system Deborah Adler, who ensured all elements of the ScriptPath system easy to read and understand, as well as developed clear icons and intuitive layout for the system.
“What’s really great about this project is it's a marriage of really crisp design voice that Deborah brings to the table and the deep clinical, innovative pharmacy technology that only CVS can bring forward,” Hourican told Drug Store News. “The marriage of the two together is what makes this project exciting to us, and we think our customers and patients are going to react to it in a favorable way.”